Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…ng renin-angiotensin-aldosterone system inhibitors (RAASi) with dapagliflozin compare to RAASi alone in children with hereditary kidney disea…
…imarily in low- and middle-SDI countries.Conclusions The global stroke burden is rising, particularly in low-SDI regions, due to agein…
…an diagnosis of TD and schizophrenia, schizoaffective disorder, bipolar disorder or major depressive disorder exhibiting ‘extra, irregular movem…
…nder prostate cancer a relatively immunologically “cold” tumor. Sipuleucel-T (Provenge), an autologous cellular immunotherapy, induces an im…
…c liver failure (ACLF) carries high short-term mortality, where corticosteroids offer limited benefit. This study evaluated the safety and impa…
…abilitation (PR) is an effective intervention for patients with chronic obstructive pulmonary disease (COPD) but impact typically only lasts 6–12 months. This paper …
…s evaluated based on word count using a readability tool.Result GPT-o1 Pro (8.80) significantly outperformed GPT-4o (6.80) and Grok 2 (6.9…
…or trials and what efforts are needed to advance use of PROs in lupus clinical trials.Meeting participants concluded that although PR…
…pholipid antibody syndrome, acute systemic lupus erythematosus, atypical haemolytic uraemic syndrome and thrombocytopenic thrombotic purpura. This can make timely c…
…racteristics and proximal colonic location with postcolonoscopy colorectal cancer (PCCRC), indicating that they may give rise to a disproportiona…
…STS injections in one ear, chosen by randomisation, before each cisplatin infusion. The contralateral ear serves as an internal control. …
…able pharmacovigilance safety signal associating PPI usage with hypertension reporting. Although a potential dose–response trend was observe…